1. Low-dose oral minoxidil improved hair growth comparably to 5% topical minoxidil in women.
2. Common side effects included mild hypertrichosis (≈15%) and peripheral edema (≈1%).
3. Topical minoxidil remains the only FDA-approved option; oral use is off-label.
4. Finasteride showed limited benefit at 1 mg/day but some improvement at higher doses.
5. Early diagnosis, individualized therapy, and regular follow-up are key for managing FPHL.

Source: The New England Journal of Medicine